Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice.
Riad A, Bien S, Gratz M, Escher F, Westermann D, Heimesaat MM, Bereswill S, Krieg T, Felix SB, Schultheiss HP, Kroemer HK, Tschöpe C.
Riad A, et al. Among authors: escher f.
Eur J Heart Fail. 2008 Mar;10(3):233-43. doi: 10.1016/j.ejheart.2008.01.004. Epub 2008 Mar 5.
Eur J Heart Fail. 2008.
PMID: 18321777
Free article.